Clinical trials
Hematologic Neoplasms trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
138 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 11 |
| 2021 | 24 |
| 2022 | 17 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 11 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Recruiting | 35 |
| Active, not recruiting | 16 |
| Terminated | 13 |
| Withdrawn | 6 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 11 |
| Duke University | 10 |
| M.D. Anderson Cancer Center | 10 |
| City of Hope Medical Center | 8 |
| Dana-Farber Cancer Institute | 6 |
| Brigham and Women's Hospital | 5 |
| Fred Hutchinson Cancer Center | 5 |
| Ohio State University Comprehensive Cancer Center | 5 |
| Thomas Jefferson University | 4 |
| University of California, San Francisco | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 138 |
| Leukemia | 19 |
| Lymphoma | 16 |
| Multiple Myeloma | 15 |
| Neoplasms | 14 |
| Myelodysplastic Syndromes | 11 |
| Leukemia, Myeloid, Acute | 8 |
| Breast Neoplasms | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Hematologic Diseases | 6 |
Trials
Showing 1 to 25 of 138. Each trial links to its page on Pharma Observatory.
38 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.